BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 26, 2003
View Archived Issues
Sodium oxybate improves pain, fatigue and sleep patterns in fibromyalgia patients
Read More
PDE inhibitor counteracts sexual dysfunction associated with fluoxetine use
Read More
Use of oxymetholone to counter HIV wasting
Read More
VIP as a potential treatment for patients with primary pulmonary hypertension
Read More
First human data and further preclinical findings discussed for CAB-175
Read More
Solifenacin succinate safe and effective in patients with overactive bladder
Read More
Four series of inhibitors of IGF-1R, IR and IRR identified at Merck
Read More
Novel alpha7 nAChR agonists and their use described by P&U (Pfizer)
Read More
Pfizer presents new PDE9 inhibitors with utility in hypertension therapy
Read More
Novel series of NR2B-selective NMDA antagonists covered by Roche patent
Read More
Roche claims new retinoid agonists with utility in emphysema, cancer and dermatological disorders
Read More
Tau protein kinase inhibitors designed by Mitsubishi and Sanofi-Synthelabo scientists
Read More
Novel series of HIV integrase inhibitors presented by Italian researchers
Read More
Higher GI-related expenses for Fosamax patients versus Actonel patients
Read More
INS-37217 Intranasal fails to meet primary endpoint in perennial allergic rhinitis trial
Read More
Phase I trial of interferon enhancer EMZ-701 completed
Read More
CPMP contraindicates concomitant use of repaglinide and gemfibrozil
Read More
Advanced Life Sciences licenses ALS-499 from Argonne National Laboratory
Read More
Novartis Generics rebranded as Sandoz
Read More
Valentis licenses delivery technology to Juvaris
Read More
Patient enrollment begins in phase II trial of ThGRF in HIV-related lipodystrophy
Read More
Speedel acquires full rights to SPP-301 from Roche
Read More
EMEA hands down positive opinion on Humira
Read More
Ipsen acquires development rights to SJG-136 from Spirogen
Read More
Biovitrum and GSK to focus efforts on highly selective 5-HT2C receptor agonists
Read More
CeNeS divests three products, allocates profits
Read More
Wyeth and Takeda sign new partnership agreements
Read More